Literature DB >> 35707474

Analysis of the Characteristics of Dominant Diseases in Traditional Chinese Medicine: Based on 95 Diseases.

Hanting Wu1, Yi Liang2, Qiushuang Li3, Peijie Hei1, Juan Liang1, Rongchen Dai1, Conghua Ji1,3.   

Abstract

Background: Traditional Chinese medicine (TCM) has been widely used all over the world and has shown its superiority in some diseases. However, there are no clear evaluation criteria for TCM. In 2019, a list of TCM dominant diseases was published by the Chinese National Administration of Traditional Chinese Medicine. This study aimed to systematically summarize the characteristics of 95 TCM dominant diseases and provide a reference for the establishment of evaluation criteria for TCM dominant diseases.
Methods: The diagnosis and treatment protocols of all the 95 TCM dominant diseases were screened. The data of disease classification, diseases' code of TCM, length of hospital stay, treatment protocols, and clinical pathways were reviewed and summarized.
Results: The diseases of the genitourinary and nervous systems accounted for 14.74% and 12.73% of the TCM dominant diseases, respectively. The length of hospital stay for 55 (57.89%) diseases was no more than less than 14 days. Each disease had its specific Chinese herbal decoction pieces and Chinese patent drugs. Chinese medical injections were not widely used. TCM external treatments for these diseases are abundant, with hundreds optional.
Conclusion: Some potentially promising TCM dominant diseases remain to be identified and deserve further research to establish the evaluation criteria of TCM dominant diseases.
Copyright © 2022 Hanting Wu et al.

Entities:  

Year:  2022        PMID: 35707474      PMCID: PMC9192295          DOI: 10.1155/2022/6972663

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.650


  20 in total

Review 1.  Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.

Authors:  R Buhl
Journal:  Allergy       Date:  2006-05       Impact factor: 13.146

2.  [The present-stage advantage diseases of abdominal acupuncture from reports of clinical randomized controlled trial].

Authors:  Zhong Di; Shuo Jiang; Yi Tian; Xian-Ming Lin
Journal:  Zhongguo Zhen Jiu       Date:  2013-09

3.  Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.

Authors:  Hong-Hu Zhu; Xiao-Jun Huang
Journal:  N Engl J Med       Date:  2014-12-04       Impact factor: 91.245

4.  ICD-11.

Authors: 
Journal:  Lancet       Date:  2019-06-06       Impact factor: 79.321

5.  Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Authors:  R Hoessel; S Leclerc; J A Endicott; M E Nobel; A Lawrie; P Tunnah; M Leost; E Damiens; D Marie; D Marko; E Niederberger; W Tang; G Eisenbrand; L Meijer
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

6.  Clinical efficacy of traditional chinese medicine on acute myocardial infarction: a prospective cohort study.

Authors:  Wen-hui Duan; Fang Lu; Li-zhi Li; Cheng-long Wang; Jian-gang Liu; Qiao-ning Yang; Feng Gu; Lei Zhang; Da-zhuo Shi
Journal:  Chin J Integr Med       Date:  2012-08-16       Impact factor: 1.978

7.  Chinese cupping: a simple method to obtain epithelial grafts for the management of resistant localized vitiligo.

Authors:  Sherif Shoukry Awad
Journal:  Dermatol Surg       Date:  2008-06-05       Impact factor: 3.398

8.  Influence and Effect of Acupoint Application of Chinese Medicine on Height and Bone Age of Children with Short Stature.

Authors:  Weiqun Wang; Hong Sun; Yushuang Ye; Zhengyang Shao; Yuping Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-29       Impact factor: 2.629

9.  Effect of Shenmai injection on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial.

Authors:  Lei Chen; Liangrong Wang; Qian Zhuo; Qiong Zhang; Feifei Chen; Liling Li; Lina Lin
Journal:  BMC Anesthesiol       Date:  2018-10-11       Impact factor: 2.217

10.  Tu Youyou winning the Nobel Prize: Ethical research on the value and safety of traditional Chinese medicine.

Authors:  Wei-Rong Zheng; En-Chang Li; Song Peng; Xiao-Shang Wang
Journal:  Bioethics       Date:  2018-07-03       Impact factor: 1.898

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.